Harvard Bioscience Inc (NASDAQ:HBIO)
| 3.80 BATS BZX Real-Time Price As of 10:44am ET |  +0.03 / +0.80%Today’s Change | 1.98 Today|||52-Week Range 6.49 | +37.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 6.7M | 5.6M | 5.7M | 8.2M | |
| Short Term Investment Cash | -7.4M | -1.1M | 137.0K | 2.4M | ||
| Cash & Short Term Investments | 6.7M | 5.6M | 5.7M | 8.2M | ||
| Receivables | Receivables | 17.5M | 15.7M | 16.2M | 21.5M | |
| Inventories | Inventories | 22.3M | 20.0M | 21.4M | 25.1M | |
| Current Assets | Other Current Assets | 3.9M | 4.2M | 4.2M | 3.1M | |
| Current Assets | 50.5M | 45.5M | 47.5M | 57.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 21.9M | 18.9M | 20.5M | 23.3M | |
| Depreciation | -16.0M | -14.6M | -16.4M | -17.4M | ||
| Intangible Assets | 62.5M | 56.7M | 57.2M | 103.1M | ||
| Other Assets | 62.8M | 56.8M | 57.5M | 104.7M | ||
| Total Assets | 120.2M | 107.8M | 109.4M | 168.6M | ||
| Liabilities | Accounts Payable | 8.8M | 6.2M | 5.4M | 7.4M | |
| Short Term Debt | 2.5M | 2.4M | 2.8M | 2.0M | ||
| Accrued Expenses | 2.5M | 2.9M | 2.5M | 1.6M | ||
| Other Current Liabilities | 4.4M | 4.3M | 3.7M | 8.3M | ||
| Other Liabilities | 19.4M | 14.6M | 14.0M | 21.5M | ||
| Total Liabilities | Long Term Debt | 16.5M | 11.4M | 9.0M | 58.8M | |
| Deferred Taxes | -2.8M | -5.3M | -3.8M | -2.1M | ||
| Other Liabilities | 185.0K | 177.0K | 266.0K | 2.4M | ||
| Total Liabilities | 42.6M | 35.6M | 28.5M | 85.9M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 77.6M | 72.2M | 80.9M | 82.7M | ||
| Total Shareholder Equity | 77.6M | 72.2M | 80.9M | 82.7M | ||
| Share Information | Common Shares Outstanding | 34.0M | 34.4M | 35.0M | 37.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
